1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
Regenerative Medicines: Bone and Joint Applications

Regenerative Medicines: Bone and Joint Applications

  • May 2015
  • 309 pages
  • ID: 157460

Summary

Table of Contents

This BCC Research report focuses on the bone- and joint-related applications of and markets for the various categories of regenerative medicine products currently available and projected to be introduced during the five-year forecast period from 2015 through 2020.

Use this report to:
- Learn about leading bone and joint diseases and disorders applicable to regenerative technologies.
- Analyze the regenerative products used to treat bone and joint disorders.
- Receive information about the regulatory issues affecting regenerative medicine products.
- Review the profiles of leading and emerging companies in the bone and joint regenerative medicine markets.

Highlights
- The U.S. market for regenerative medicine products used in bone and joint applications is expected to grow at a compound annual growth rate (CAGR) of 6.8% from $2.9 billion in 2015 to nearly $4.1 billion in 2020.
- Bone replacement/grafting as a segment will grow from nearly $2.1 billion in 2015 to nearly $2.8 billion in 2020 at 5.9% CAGR for the period 2015-2020.
- Cell therapy/tissue engineering/cartilage as a segment will grow from $255 million in 2015 to $460 million by 2020, increasing at a CAGR of 12.5% for the period 2015-2020.

Introduction & Scope

INTRODUCTION
Regenerative medicine in orthopedic applications is a $2.9 billion per year niche sector in America’s $3.1 trillion per year healthcare system. However, it is a sector of
immense interest in terms of technical, medical and investment possibilities. The best analogy to the current state of regenerative therapies in the bone and joint healing
sector is the nascency of the microprocessors business back in 1971. At that time, microprocessors (namely Intel’s 4004), and related innovations, were just an infinitesimal segment of electronic component sales, but this innovation came to dominate the economy. The regenerative therapies sector, particularly areas such as cell therapy, genetic engineering and stem cell-derived products is in a comparable position today. A good example is Bluebird Bio, which received FDA designated breakthrough therapy status in February 2015 for one of the company’s gene therapies.

The regenerative medicine industry has been in existence for nearly 25 years. Actual product sales, along with research and development (R&D) expenditures, are projected
to amount to approximately $2.9 billion in economic activity in 2015, of which venture capital and R&D funding accounts for about $200 million. The rapid evolution of this
business is evidenced by the industry consolidation that has occurred since the first edition of this BCC Research report was published in 2003 and even since the most recent edition in 2013. Innumerable buyouts, consolidations, product abandonments, new firms and a few bankruptcies, too, have occurred in just the last several years. These changes are reflected in the Company Profiles section of this report. In addition, intensive R&D efforts at universities, the National Institutes of Health, the National Science Foundation and at FDA centers that focus on cutting-edge technology underscore the importance of this industry.

Regenerative therapies have the potential to improve medical outcomes, enhance quality of life and reduce overall healthcare costs. A key objective is the utilization of
living cells to repair or replace body tissue damaged by injury, disease or the aging process. The most successful products have drawn upon multidisciplinary fields such as
biology, medicine, engineering and, particularly, biomedical engineering. The principal focus in this report is on bone and joint applications; however, other regenerative
applications such as dental, neurologic, organ regeneration, cardiovascular, urologic, diabetes and wound care are important and are briefly covered to underscore the
larger importance of regenerative therapies. Stem-cell research is an important component of the sector as well. For example, the successful differentiation of embryonic stem cells into specific cell types is widely sought as a means to treat traumatic spinal-cord injury, as well as diseases such as diabetes, Duchene muscular dystrophy, heart disease, and vision and hearing loss.

OBJECTIVES AND GOALS OF STUDY
This report focuses on the bone- and joint-related applications of and markets for the various categories of regenerative medicine products currently available and projected
to be introduced during the five-year forecast period from 2015 through 2020. Market drivers discussed include the status of R&D and what is likely to issue from R&D in the
way of actual products and therapies. Other market drivers include the incidence, and rate of growth, of diseases and disorders that will benefit from these products, primarily arthritis, osteoporosis, and various types of bone and joint trauma (e.g., hip fractures, knee injuries); increasing use of nonautograft products by physicians; and
innovative devices that incorporate bone- and cartilage–growth-stimulating agents in a regenerative appliance. Products discussed include bone and cartilage grafting and
regenerative products derived from autologous, allogeneic and synthetic sources, as well as electrical stimulators for bone growth and regenerative cartilage products.
Profiles are provided of leading and emerging companies in the bone and joint regenerative medicine markets, along with analyses of the current and future positioning of their products and businesses in this active and rapidly changing market. Developmental and clinical stage companies are well covered.

INTENDED AUDIENCE
The aim of this report is to provide an overview of regenerative medicine products, both available and emerging, for the treatment of diseases and disorders of the bones
and joints. The information and analysis presented are important assets in decision making for managers involved in business development, marketing, market research,
product development, mergers and acquisitions, licensing, business management, investment banking and deal creation, as well as for consultants to the pharmaceutical
and biotechnology industries. The study provides a comprehensive analysis of the current markets for regenerative medicine products for bones and joints, relevant
applications, and the potential of products in development.

STUDY SCOPE AND FORMAT
The U.S. has been the main regenerative medicine market in terms of R&D innovation, patents and product sales often accounting for as much as half of the market
depending on the product niche; hence, the scope of the study is mainly the U.S., although worldwide developments are discussed and measurements provided where
relevant. The Overview section provides a background of the demographics underlying the market for bone and joint products, a definition of regenerative medicine and the
technologies involved, and a discussion of regenerative products in development for applications other than bones and joints. Various application sections describe the
leading bone and joint diseases and disorders applicable to regenerative technologies, including incidence and current methods of treatment.

The section on Products provides extensive descriptions and analyses (e.g., comparative analysis) of regenerative products used to treat bone and joint disorders,
as well as a discussion of products in development. The section on FDA clinical trials and newly approved products provides a discussion of regulatory issues affecting regenerative medicine products. An extensive Company Profiles section provides estimates for the revenues of the leading companies and a concise description of leading and emerging companies in the area of regenerative products for bones and joints, including product introductions, patents and overall business strategies.

METHODOLOGY
Both primary and secondary research methodologies were used to prepare this market research report. The base year for this study is 2014. Data for 2015 are estimated and
2020 is the forecast terminal year. Sales data are estimated in nominal current dollars, unadjusted for inflation. Information to prepare this study was derived from market
intelligence provided by leading companies involved in the regenerative medicine market. Data were accessed from government agencies such as the SEC and regulatory bodies (FDA, EMA) that monitor and/or regulate medical devices. Searches of secondary material such as company annual reports and 10Ks, medical journal articles, prospectus assessments, government resources and data from healthcare institutions were conducted. In addition, the study author attended the 2015 Third Annual Alliance for Regenerative Medicine Investor’s Conference in New York in order to conduct primary interviews with industry contacts.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Regenerative Medicine Market 2018-2022

Regenerative Medicine Sector: Worldwide Forecast until 2022

  • $ 2500
  • Industry report
  • April 2018
  • by Infiniti Research Limited

About Regenerative MedicineRegenerative medicine augments, repairs, replaces or regenerates organs and tissue that have been damaged by disease, injury, or even by the natural aging process.Technavio’s ...

Cell Harvesting Market by Type, Application, End User And Region - Global Forecasts to 2023

Cell Harvesting Market: Global Forecasts until 2023

  • $ 5650
  • Industry report
  • March 2018
  • by MarketsandMarkets

The cell harvesting market is projected to grow at a CAGR of 8.7%.The cell harvesting market is estimated at USD 213.87 million in 2018 and expected to grow at a CAGR of 8.7% to reach USD 324.5 million ...

Translational Regenerative Medicine Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023

Translational Regenerative Medicine Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023

  • $ 4795
  • Industry report
  • March 2018
  • by Infinium

The report on global translational regenerative medicine market provides qualitative and quantitative analysis for the period of 2015 to 2023.The report predicts the global translational regenerative medicine ...


ref:plp2015

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on